These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2379562

  • 1. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
    Bögli C, Cofrancesco E, Cortellaro M, Della Volpe A, Hofer A, Furlan M, Zanussi C.
    Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562
    [Abstract] [Full Text] [Related]

  • 2. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C, Hofer A, Baudo F, Redaelli R, Furlan M.
    Haemostasis; 1992 Jul; 22(1):7-11. PubMed ID: 1521828
    [Abstract] [Full Text] [Related]

  • 3. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
    Bolliger-Stucki B, Lord ST, Furlan M.
    Blood; 2001 Jul 15; 98(2):351-7. PubMed ID: 11435303
    [Abstract] [Full Text] [Related]

  • 4. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
    Borrell M, Vila L, Solá J, Coll I, Fontcuberta J.
    Haemostasis; 1990 Jul 15; 20(1):1-7. PubMed ID: 2323678
    [Abstract] [Full Text] [Related]

  • 5. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
    Loreth RM, Meyer M, Albert FW.
    Haemostasis; 2001 Jul 15; 31(1):12-7. PubMed ID: 11408744
    [Abstract] [Full Text] [Related]

  • 6. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
    Furlan M, Leupin L, Biasiutti FD, Lämmle B.
    Schweiz Med Wochenschr; 1991 Jul 20; 121(29):1068-71. PubMed ID: 1891701
    [Abstract] [Full Text] [Related]

  • 7. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
    Yoshida N, Wada H, Morita K, Hirata H, Matsuda M, Yamazumi K, Asakura S, Shirakawa S.
    Blood; 1991 May 01; 77(9):1958-63. PubMed ID: 2018836
    [Abstract] [Full Text] [Related]

  • 8. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.
    Siebenlist KR, Prchal JT, Mosesson MW.
    Blood; 1988 Mar 01; 71(3):613-8. PubMed ID: 3345340
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen.
    Seydewitz HH, Gram J, Bruhn HD, Witt I.
    Blood Coagul Fibrinolysis; 1991 Aug 01; 2(4):501-6. PubMed ID: 1768762
    [Abstract] [Full Text] [Related]

  • 11. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
    Lundberg UG, Rodriguez S, Marchi R, Ruiz-Saez A, Arocha-Piñango CL.
    Thromb Res; 1995 Apr 15; 78(2):95-106. PubMed ID: 7482436
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F, Koopman J, Kluft C, D'Angelo A, Cattaneo M, Mannucci PM.
    Thromb Haemost; 1986 Feb 28; 55(1):131-5. PubMed ID: 3705000
    [Abstract] [Full Text] [Related]

  • 16. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
    Stucki B, Zenhäusern R, Biedermann B, Baudo F, Redaelli R, Lämmle B, Furlan M.
    Blood Coagul Fibrinolysis; 1999 Mar 28; 10(2):93-9. PubMed ID: 10192658
    [Abstract] [Full Text] [Related]

  • 17. Fibrinogen Sapporo: dysfibrinogenemia characterized by the replacement of A alpha arginine-16 by histidine resulting in the delayed release of fibrinopeptide A by thrombin.
    Asakura S, Terukina S, Yamazumi K, Matsuda M, Murayama H, Higuchi A, Musashi M, Sakurada K, Miyazaki T.
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep 28; 52(6):1094-104. PubMed ID: 2588959
    [Abstract] [Full Text] [Related]

  • 18. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
    Ebert RF, Schreiler WE, Bell WR.
    Thromb Res; 1986 Jul 01; 43(1):7-13. PubMed ID: 3726812
    [Abstract] [Full Text] [Related]

  • 19. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
    Meyer M, Kutscher G, Stürzebecher J, Riesener G, Lutze G.
    Thromb Res; 2003 Jan 25; 109(2-3):145-51. PubMed ID: 12706644
    [Abstract] [Full Text] [Related]

  • 20. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B, Stenbjerg S, Dyr J, Kudryk B, Therkildsen L, Blombäck B.
    Thromb Res; 1986 Apr 01; 42(1):21-37. PubMed ID: 2939591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.